PATENT CLAIM ANALYSIS

Application Number: 15772995
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "265100"]

Abstract:
The present invention relates to a 7-(thiazol-5-yl)pyrrolopyrimidine compound as a TLR7 agonist, and particularly relates to a compound shown in formula (I), pharmaceutically acceptable salt and preparation method thereof, a pharmaceutical composition containing such a compound, and usage thereof in preparing an antiviral drug.

Claim (Index 20):
The method according to  claim 19 , wherein the viral infection is hepatitis B or hepatitis C viral infection.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 93.0
- Lexical Diversity: 1.44737
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15955523', '15503977', '15378576', '12383071', '16075303']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7471334394206204
- 35 USC 102 Novelty (BERT): 0.5361332463982884
- Combined Prediction Score: 0.7260334201183872
- Mean Citation Score: 280.63278
- Max Citation Score: 334.58817
- Similarity Product: 209.0044895028448

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test